Abstract
The authors would like to make the following corrections to this published paper [1]. In the original manuscript, Figure 10A contained an error in the labeling of the X-axis (Log Dilution). The correct dilutions used for the serum were from 1/20 to 1/160, which correspond to log dilutions approximately from log 1.3 to log 2.2. Therefore, the X-axis should have been labeled as 1.2 to 2.4, rather than 2.2 to 3.4. We apologize for this oversight and have corrected the figure accordingly to reflect the accurate dilution range. The corrected Figure 10 is listed below: The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
| Original language | English |
|---|---|
| Article number | 1189 |
| Journal | Vaccines |
| Volume | 12 |
| Issue number | 10 |
| DOIs |
|
| Publication status | Published - Oct 2024 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Correction to: Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes (Vaccines, (2024), 12, 8, (874), 10.3390/vaccines12080874)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver